Welcome to the e-CCO Library!

P335 Treatment strategies after mucosal healing (MH) in ulcerative colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Sitibondo1, A. Viola1, G. Costantino1, A. Centritto1, A. Belvedere1, V. Pisana1, A. Abbruzzese1, A. Alibrandi2, W. Fries1

Created: Thursday, 30 January 2020, 10:12 AM
P335: A prospective multicentre “real-life” international validation study of the PICaSSO endoscopic scoring system against histologic scoring system to define mucosal healing in ulcerative colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Iacucci1,2*, M. Lazarev3, G.E. Tontini4, M. Daperno5, M. Goetz6, X. Gui7, V. Villanacci8, B.C. Lethebe9, M. Vecchi4, G. De Hertogh10, R. Mannan11, R. Hejmadi12, S. Smith2, U. Shivagi2, P. Bhandari13, S. Ghosh2, R. Kiesslich14, R. Bisschops15

Created: Thursday, 21 February 2019, 9:14 AM
P335: Cancer recurrence with immunosuppressive therapy in immune-mediated diseases: a systematic review and meta-analysis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

E. Shelton*1, D. Laharie2, F. Scott3, R. Mamtani4, J. Lewis4, J.-F. Colombel5, A. Ananthakrishnan1

Created: Friday, 22 February 2019, 9:49 AM
P335: Impact of cancer therapy on the course of Inflammatory Bowel Disease (ONCOEII study of GETECCU)
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Pérez Galindo, P.(1)*;Benítez, J.M.(2);Rubín de Célix, C.(3);Mesonero, F.(4);Castaño García, A.(5);García, M.J.(6);Vicuña, M.(7);Bernal, L.(8);Bertoletti, F.(9);Ramírez Castro, C.(10);Sánchez-Azofra, M.(11);Sánchez-Delgado, L.(12);Ponferrada, Á.(13);Tejido Sandoval, C.(14);Capilla, M.(15);Laredo de la Torre, V.(16);Diz-Lois, M.T.(17);Dueñas Sadornil, C.(18);García-Morales, N.(19);González-Vivo, M.(20);López-Cauce, B.(21);Melcarne, L.(22);Calviño-Suárez, C.(23);Lastiri González, E.(24);Ramírez de la Piscina, P.(25);Pérez-Gisbert, J.(3);Pérez Martínez, I.(5);Castro, B.(6);Cousillas, A.(26);Mañosa, M.(27);Carpio, D.(1);Barreiro-de Acosta, M.(23);
Created: Friday, 14 July 2023, 11:05 AM
P335: Long-term follow-up of switching from original infliximab to infliximab biosimilar: real-world data
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Guerra Veloz*1, M. Belvis Jimenez1, T. Valdes Delgado1, L. Castro Laria1, B. Maldonado Pérez1, A. Benítez Roldán1, R. Perea Amarillo1, V. Merino Bohorquez2, M. A. Calleja Hernandez2, A. Caunedo Álvarez1, A. Vilches Arenas3, F. Argüelles-Arias1

Created: Friday, 22 February 2019, 9:41 AM
P335: Prevalence and risk factors for non alcoholic fatty liver disease in inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Iannone A.*1, Losurdo G.2, Shahini E.1, Albano F.1, La Fortezza R.F.1, Rizzi S.F.1, Contaldo A.1, Barone M.1, Ierardi E.1, Principi M.1, Di Leo A.1

Created: Wednesday, 20 February 2019, 10:36 AM
P335: Real-life effectiveness and safety of tofacitinib treatment in patients with ulcerative colitis: A KASID multicenter cohort study
Year: 2021
Source: ECCO'21 Virtual
Authors: Oh, K.(1);Hong, S.N.(2);Kim, E.S.(3);Na, S.Y.(4);Kang, S.B.(5);Koh, S.J.(6);Bang, K.B.(7);Jung, S.A.(8);Kim, K.O.(9);Choi, C.H.(10);Ye, B.D.(11);
Created: Wednesday, 2 June 2021, 4:12 PM
P335: Utility of Intestinal Ultrasound in Monitoring Disease Activity in Ulcerative Colitis Patients Treated with Biologics
Year: 2022
Source: ECCO'22
Authors: Tomašić, V.(1);Kralj, D.(1);Bišćanin, A.(1);Ćaćić, P.(1);Ogresta, D.(1);Dorosulić, Z.(1);Hrabar, D.(1);
Created: Friday, 11 February 2022, 3:52 PM
P336 Minimally invasive surgery is safe and feasible for luminal Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Nnaji, Y.F. Chin, O. Pujji, B. Wilkinson, S. Mohan, N.A. Yassin

Created: Thursday, 30 January 2020, 10:12 AM
P336: Association between the prior duration of remission and efficacy outcomes in patients with Ulcerative Colitis treated with tofacitinib 10 mg twice daily who were in stable remission and either dose-reduced to tofacitinib 5 mg twice daily or remained on 10 mg twice daily: 6-month data from the double-blind, randomised RIVETING study
Year: 2021
Source: ECCO'21 Virtual
Authors: Dubinsky, M.C.(1);D’Haens, G.R.(2);Sandborn, W.J.(3);Ng, S.C.(4);Panés, J.(5);Su, C.(6);Lawendy, N.(6);Lazariciu, I.(7);Gardiner, S.(7);Mundayat, R.(7);Kulisek, N.(6);Modesto, I.(7);Torres, J.(8);
Created: Wednesday, 2 June 2021, 4:12 PM
P336: Behavioural treatment options for psychological comorbidities in patients with inflammatory bowel disease: a systematic literature review
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

L. Keefer1, R. Cheung*2, M. Bernauer3, D. Patel2, M. Dubinsky1

Created: Friday, 22 February 2019, 9:41 AM
P336: Can Mesenchymal Stem Cell (MSC) apoptosis be used as a biomarker for treatment success in perianal fistulising Crohn’s Disease (pCD)? Findings from a prospective pilot study
Year: 2022
Source: ECCO'22
Authors: Iqbal, N.(1,2);Constable, L.(3,4);Tozer, P.(1,2);Lung, P.(1);Hart, A.(1,4);Powell, N.(4);
Created: Friday, 11 February 2022, 3:52 PM
P336: Endoscopic scores as predictors of treatment failure in Ulcerative Colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Ferreira, A.I.(1)*;Lima Capela, T.(1);Xavier, S.(1);Arieira, C.(1);Cúrdia Gonçalves, T.(1);Dias de Castro, F.(1);Moreira, M.J.(1);Cotter, J.(1);
Created: Friday, 14 July 2023, 11:05 AM
P336: French prospective, longitudinal observational study of the therapeutic management of mild to moderate ulcerative colitis (Optimum study): follow-up at 3 years
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Nahon*1, G. Bonnaud2, F. Bahbah3

Created: Friday, 22 February 2019, 9:49 AM
P336: Is endoscopy necessary to measure disease activity in ulcerative colitis: A systematic narrative review
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Restellini1,2*, C.-Y. Chao1,3, O. Kherad4, M. Martel5, A.N. Barkun1, E. Seidman1, G. Wild1, A. Bitton1, W. Afif1, T. Bessissow1, P.L. Lakatos1,6

Created: Thursday, 21 February 2019, 9:14 AM
P336: Safety of anti-TNF treatment in older IBD patients: a systematic review and meta-analysis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Waars S.1, Dekkers N.1, van der Meulen A.1, Stijnen T.2, Maljaars J.*1

Created: Wednesday, 20 February 2019, 10:36 AM
P337 Usefulness of drug-level monitoring in therapeutic guidance in patients with ulcerative colitis on anti-TNF-α maintenance therapy
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E.H. Oh1, Y. A-Ran2, K. Ye-Jee3, K. Jeongseok1, N. Namseok1, P. Sang Hyoung4, Y. Dong-Hoon1, B. Jeong-Sik1, M. Seung-Jae1, Y. Suk-Kyun4, Y. Byong Duk4

Created: Thursday, 30 January 2020, 10:12 AM
P337: Anti-TNFalpha therapy is associated with rapid reduction of circulating monocyte numbers and blunted monocyte pro-inflammatory response in patients with Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Slevin*1, C. Dennedy2, A. Ribeiro1, R. Ceredig1, M. Griffin1, L. Egan2

Created: Friday, 22 February 2019, 9:49 AM
P337: Developing Preliminary MRI-based Classifier for Perianal Fistulizing Crohn's Disease by Using Deep Convolutional Neural Networks
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Zhang, H.(1)*;Li, L.(2);Deng, K.(2);Li , W.(3);Ren, D.(1);
Created: Friday, 14 July 2023, 11:05 AM
P337: Early infliximab clearance predicts remission in children with Crohn’s Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Chung, A.(1);Carroll, M.(1);Almeida, P.(1);Petrova, A.(1);Mould, D.(2);Wine, E.(1);Huynh, H.(1);
Created: Wednesday, 2 June 2021, 4:12 PM